CLINICAL_TRIALS trial_result · 2025-03-19

Clinical Trial Update: A Study of BAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP) [Phase 3]

This Phase 3 study of BAX 930 in children, teenagers, and adults with thrombotic thrombocytopenic purpura has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Baxalta now part of Shire | Conditions: Thrombotic Thrombocytopenic Purpura (TTP) | Phase 3 | Status: COMPLETED | Results posted: 2025-03-19